Nootropic peptides and brain health
Focus, memory, and mood all ride on how well brain cells signal and repair. Nootropic peptides — semax and selank are the ones most people ask about — were developed in Russian research programs and are studied for cognitive support and calm focus.
These articles unpack how they're thought to work, what the human evidence actually looks like, and how prescribed use differs from what you might read on forums. A licensed provider reviews every request; not everyone qualifies.
19 articles on this topic
-
GLP-1 Schizophrenia Study: What the Hospital Data Means
An October 2026 U.S. study linked starting a GLP-1 drug in adults with schizophrenia and type 2 diabetes to a lower psychiatric hospitalization hazard. These drugs are not FDA-approved for schizophrenia, and health records cannot prove cause and effect.
-
Who Discovered Semax? Its Russian Origins
Igor Ashmarin, Nikolai Myasoedov and a Moscow team developed Semax. Its history runs from modified hormone fragments to Russian registration and U.S. review.
-
Semax Side Effects: What the Safety Data Shows
Mild nasal irritation is documented, but reliable rates for other reactions are missing. The small studies leave important safety questions unanswered.
-
Semax News Update: October 2026
FDA’s advisory panel supported listing Semax for compounding in July. The published list and the limits of the human studies still matter.
-
Semaglutide Alzheimer's Trial: What EVOKE Found
Two large trials gave people with early Alzheimer's disease a daily semaglutide tablet or a placebo for two years. Decline was the same in both groups. Here is what was measured, what moved, and what is still unanswered.
-
Semax FDA History: What the July Vote Changed
Semax has never had an FDA-approved U.S. product. A July 2026 advisory vote supported possible 503A listing, but it did not add Semax to the list or approve a drug.
-
Semax Half-Life: The Honest Answer Is Unknown
There is no measured Semax half-life in humans. Rat studies show that intact Semax reaches the brain within minutes and breaks down quickly, but they do not supply a reliable human clock.
-
Semax Selank Nasal Spray: What the Route Changes
A Semax Selank nasal spray puts both peptides in one intranasal liquid, but there is no universal recipe. The route, concentration, pump, and prescription all matter—the Russian studies used nasal drops and sprays, while the blend Promise offers by prescription is an injectable vial.
-
DSIP Nasal Spray: What the Human Research Says
A DSIP nasal spray appears in one small human experiment, but no published human nasal PK or sleep trial validates the format. Promise currently lists DSIP as an injection, not a spray.
-
Selank Dosage: What Human Studies Actually Used
Russian human studies most clearly report 2.7 mg per day intranasally for 14 days, but that fixed study protocol is not a personal dosing guide and does not convert to an injectable Semax/Selank blend.
-
Selank for Anxiety: What the Research Shows
Three small Russian trials, 192 patients, and no placebo arm between them. Here is what that evidence supports, what it doesn't, and where US regulators have landed.
-
Semax for ADHD: What the Evidence Actually Shows
Semax has not been tested in a human ADHD trial. The attention claims come from a small study in healthy volunteers, neurological research, and a biological hypothesis—not evidence that it treats ADHD.
-
What Is Semax Used For? Evidence and Status
Semax is used in Russia for defined neurological and optic-nerve indications. In the United States, interest centers on focus and memory, but the human evidence for those nootropic uses is small and indirect.
-
DSIP Benefits: What the Human Evidence Shows
DSIP has been studied most directly for sleep, but the human findings are small, old and mixed. Signals involving ACTH, chronic pain and withdrawal are preliminary rather than established benefits.
-
N-Acetyl Semax Amidate: Claims vs Evidence
N-acetyl Semax amidate caps both ends of Semax, but the stability and potency claims run ahead of the evidence: no published human trial has tested this variant.
-
Oxytocin Peptide Beyond the 'Love Hormone'
A 2025 meta-analysis pooling 20 effect estimates from 13 human studies found no overall effect of oxytocin on non-social executive function — one number that explains why this molecule's science reads nothing like its nickname.
-
What Is Selank Used For?
Selank is a Russian-developed heptapeptide studied mostly for anxiety, and its pivotal human trial put 62 patients with generalized anxiety disorder and neurasthenia head to head against the benzodiazepine medazepam.
-
The Difference Between Semax and Selank
Both peptides are seven amino acids long and share the same Pro-Gly-Pro tail; what separates them is parentage — Semax comes from a fragment of a pituitary hormone, Selank from a fragment of an antibody.
-
Semax Peptide: How It Works in the Brain
How does the Semax peptide work? Most of the mechanism evidence is rodent, the human evidence is intranasal, and the real picture is narrower — and more interesting — than the internet suggests.